Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: No clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders

Medical Hypotheses

Volumn 67, Issue 2, 2006, Pages 311-317

  Schmitt, H Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME;

ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CYTOPLASM; HUMAN; INFORMATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UBIQUITINATION;

ALZHEIMER DISEASE; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; PROTEASOME ENDOPEPTIDASE COMPLEX; SYNAPTIC TRANSMISSION; UBIQUITIN;

EID: 33744767744     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.02.023     Document Type: Article

References (100)

1. Annaert W., Cupers P., Saftig P., and De Strooper B. Presenilin function in APP processing. Ann NY Acad Sci 920 (2000) 158-164
2. Aravamudan B., and Broadie K. Synaptic Drosophila UNC-13 is regulated by antagonistic G-protein pathways via a proteasome-dependent degradation mechanism. J Neurobiol 54 (2003) 417-438
3. Arora S., Yang J.M., and Hait W.N. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase. Cancer Res 65 (2005) 3806-3810
4. Baker S.P., and Grant P.A. The proteasome: not just degrading any more. Cell 123 (2005) 361-363
5. Bayer T.A., and Multhaup G. Involvement of amyloid β precursor protein (AβPP) modulated copper homeostasis in Alzheimer's disease. J Alzheimers Dis 8 (2005) 201-206
6. Beal R., Deveraux Q., Xia G., Rechsteiner M., and Pickart C. Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci USA 93 (1996) 861-866
7. Beninga J., and Goldberg A.L. Function of the proteasome in antigen presentation. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 191-223
8. Beyreuther K., and Masters C. Amyloid precursor protein (APP) and βA4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function. Brain Pathol 1 (1991) 241-252
9. Bingol B., and Schuman E.-M. Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 15 (2005) 536-541
10. Blass J.P. The mitochondrial spiral: an adequate cause of dementia in the Alzheimer's syndrome. Ann NY Acad Sci 924 (2000) 170-183
11. Bowman A.B., Yoo S.Y., Dantuma N.P., and Zoghbi H.Y. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14 (2005) 679-691
12. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L., et al. BACE1 is the major α-secretase for generation of Aβ peptides by neurons. Nat Neurosci 4 (2001) 233-234
13. Chain D.G., Casadio A., Schacher S., Hegde A.N., Valbrun M., Yamamoto N., et al. Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia. Neuron 22 (1999) 147-156
14. Checler F., da Costa C.A., Ancolio K., Chevallier N., Lopez-Perez E., and Marambaud P. Role of the proteasome in Alzheimer's disease. Biochim Biophys Acta 1502 (2000) 133-138
15. Christianson J.C., and Green W.N. Regulation of nicotinic receptor expression by the ubiquitin-proteasome system. EMBO J 23 (2004) 4156-4165
16. Ciechanover A. Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). Angew Chem Int Ed Engl 44 (2005) 5944-5967
17. Cooper P.N., Jackson M., Lamox G., Lowe J., and Mann D.M.A. τ, Ubiquitin and αB-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 52 (1995) 1011-1015
18. 35S]GTP gamma S binding shows regional selective changes in Alzheimer's disease postmortem brain. Neurodegeneration 5 (1996) 19-26
19. Cowburn R.F., Fowler C.J., and O'Neill C. Neurotransmitter receptor/G-protein mediated signal transduction in Alzheimer's disease brain. Neurodegeneration 5 (1996) 483-488
20. Dalton W.S. The proteasome. Semin Oncol 31 6 Suppl. 16 (2004) 3-9
21. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 (1990) 457-464
22. Demartino G.N. Purification of PA700, the 19S regulatory complex of the 26S proteasome. Methods Enzymol 398 (2005) 295-306
23. De Vrij F.M., Sluijs J.A., Gregori L., Fischer D.F., Hermens W.T., Goldgaber D., et al. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J 15 (2001) 2680-2688
24. DiAntonio A., and Hicke L. Ubiquitin-dependent regulation of the synapse. Annu Rev Neurosci 27 (2004) 223-246
25. Di Napoli M., and McLaughlin B. The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors. Curr Opin Investig Drugs 6 (2005) 686-699
26. Fergusson J., Landon M., Lowe J., Dawson S.P., Layfield R., Hanger D.P., et al. Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci Lett 219 (1996) 167-170
27. Ferrington D.A., Sun H., Murray K.K., Costa P., Williams T.D., Bigelow D.J., et al. Selective degradation of oxidized calmodulin by the 20S proteasome. J Biol Chem 276 (2001) 937-943
28. Finley D., and Varshavsky A. The ubiquitin system: functions and mechanisms. Trends Biochem Sci 10 (1985) 343-346
29. Fraser P.E., Levesque G., Yu G., Mills R., Thirlwell J., Frantseva M., et al. Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol Aging 19 1 Suppl (1998) S19-S21
30. Glickman M.H., and Raveh D. Proteasome plasticity. FEBS Lett 579 (2005) 3214-3223
31. Gerez L., de Haan A., Hol E.M., Fischer D.F., van Leeuwen F.W., van Steeg H., et al. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for β-amyloid precursor protein and ubiquitin B. Neurobiol Aging 26 (2005) 145-155
32. Goldberg A.L., and Rock K.L. Proteolysis, proteasomes and antigen presentation. Nature 357 (1992) 375-379
33. Gregori A.L., Fuchs C., Figueiredo-Pereira M.E., Van Nostrand W.E., and Goldgaber D. Amyloid β protein inhibits ubiquitin-dependent protein degradation in vivo. J Biol Chem 270 (1995) 19702-19708
34. Gregori L., Hainfeld J.F., Simon M.N., and Goldgaber D. Binding of amyloid β protein to the 20S proteasome. J Biol Chem 272 (1997) 58-62
35. Groll M., and Huber R. Purification, crystallization, and X-ray analysis of the yeast 20S proteasome. Methods Enzymol 398 (2005) 329-336
36. Hegde A.N. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog Neurobiol 73 (2004) 311-357
37. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67 (1998) 425-479
38. Hilt W., and Wolf D.H. Proteasomes: destruction as a programme. Trends Biochem Sci 21 (1996) 96-102
39. Hishikawa N., Hashizume Y., Yoshida M., and Sobue G. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl) 105 (2003) 341-350
40. Hipkiss A.R. Could carnosine suppress zinc-mediated proteasome inhibition and neurodegeneration? Therapeutic potential of a non-toxic but non-patentable dipeptide. Biogerontology 6 (2005) 147-149
41. Hochstrasser M., and Kornitzer D. Ubiquitin-dependent degradation of transcription regulators. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 279-302
42. Hol E.M., van Leeuwen F.W., and Fischer D.F. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B(+1). Trends Mol Med 11 (2005) 488-495
43. Honda T., Yasutake K., Nihonmatsu N., Mercken M., Takahashi H., Murayama O., et al. Dual roles of proteasome in the metabolism of presenilin 1. J Neurochem 72 (1999) 255-261
44. Ikeda K., Akiyama H., Sahara N., Mori H., Sakata M., Mizutani T., et al. Senile dementia with abundant neurofibrillary tangles without accompanying senile plaques: a subset of senile dementia with high incidence of the APOE ε2 allele. In: Iqbal K., Winblad B., Nishimura T., Takeda M., and Wisniewski H.M. (Eds). Alzheimer's disease: biology, diagnosis and therapeutics (1997), Wiley, Chichester, UK 257-265
45. Johansson B.B., Minsaas L., and Aragay A.M. Proteasome involvement in the degradation of the G family of Gα subunits. FEBS J 272 (2005) 5365-5377
46. Kawahara H., and Yokosawa H. Intracellular calcium mobilization regulates the activity of 26S proteasome during the metaphase-anaphase transition in the ascidian meiotic cell cycle. Dev Biol 166 (1994) 623-633
47. Kim T.W., Pettingell W.H., Hallmark O.G., Moir R.D., Wasco W., and Tanzi R.E. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem 272 (1997) 11006-11010
48. Kopito R.R. Ubiquitination of integral membrane proteins and proteins in the secretory pathway. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 389-409
49. Kopp F., Hendil K.B., Dahlmann B., Kristensen P., Sobek A., and Uerkvitz W. Subunit arrangement in the human 20S proteasome. Proc Natl Acad Sci USA 94 (1997) 2939-2944
50. Kuo C.T., Jan L.Y., and Jan Y.N. Dendrite-specific remodeling of Drosophila sensory neurons requires matrix metalloproteases, ubiquitin-proteasome, and ecdysone signaling. Proc Natl Acad Sci USA 102 (2005) 15230-15235
51. Lang-Rollin I., Rideout H., and Stefanis L. Ubiquitinated inclusions and neuronal cell death. Histol-Histopathol 18 (2003) 509-517
52. Lee D., Ezhkova E., Li B., Pattenden S.G., Tansey W.P., and Workman J.L. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123 (2005) 423-436
53. Lee H.W., Smith L., Pettit G.R., Vinitsky A., and Smith J.B. Ubiquitination of protein kinase C-α and degradation by the proteasome. J Biol Chem 271 (1996) 20973-20976
54. Leeuwen F.W.v., and Hol E.M. Molecular misreading of genes in down syndrome as a model for the Alzheimer type of neurodegeneration. J Neural Transm Suppl 57 (1999) 137-159
55. Lowe J., and Spillantini M.G. Non-Alzheimer degenerative dementias. Brain Pathol (1998) 295-297
56. Lupas A., and Baumeister W. The 20S proteasome. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 127-146
57. Marambaud P.-., Chevallier N., Barelli H., Wilk S., and Checler F. Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells. J Neurochem 68 (1997) 698-703
58. Marambaud P., Lopez-Perez E., Wilk S., and Checler F. Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's β-amyloid precursor protein: different control of early and late events by the proteasome. J Neurochem 69 (1997) 2500-2505
59. Marambaud P., Alves da Costa C., Ancolio K., and Checler F. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPα secretion: control by the proteasome. Biochem Biophys Res Commun 252 (1998) 134-138
60. 42 recovery from human cells. Mol Med 4 (1998) 147-157
61. Matsuzawa S., Cuddy M., Fukushima T., and Reed J.C. Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway. Proc Natl Acad Sci USA 102 (2005) 14982-14987
62. Mayer R.J., Landon M., and Lowe J. Ubiquitin and the molecular pathology of human disease. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 429-462
63. Meier-Ruge W.A., and Bertoni-Feddari C. Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type. Ann NY Acad Sci 826 (1997) 229-241
64. Mori H., Kondo J., and Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235 (1987) 1641-1644
65. Mundy D.I. Identification of the multicatalytic enzyme as a possible γ-secretase for the amyloid precursor protein. Biochem Biophys Res Commun 204 (1994) 333-341
66. Nahreini P., Andreatta C., and Prasad K.N. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells. Cell Mol Neurobiol 21 (2001) 509-521
67. Nestler E.J., and Duman R.S. G proteins. In: Siegel G.J., Agranoff B.W., Wayne R., Fisher S.K., and Uhler M.D. (Eds). Basic neurochemistry. sixth ed. (1999), Lippincott-Raven, Philadelphia, New York 401-414
68. Oberdorf J., Webster J.M., Zhu C.C., Luo S.G., and Wojcikiewicz R.J. Down-regulation of types I-III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway. Biochem J 339 Pt 2 (1999) 453-461
69. Oh S., Hong H.S., Hwang E., Sim H.J., Lee W., Shin S.J., et al. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 126 (2005) 1292-1299
70. Pak D.T., and Sheng M. Targeted protein degradation and synapse remodeling by an inducible protein kinase. Science 302 (2003) 1368-1373
71. Panayi A., Spyrou N.M., Iversen B.S., White M.A., and Part P. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195 (2002) 1-10
72. Patrick G.N., Bingol B., Weld H.A., and Schuman E.M. Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs. Curr Biol 13 (2003) 2073-2081
73. Peters J.M. Proteasomes: protein degradation machines of the cell. Trends Biochem Sci 19 (1994) 377-482
74. Petrucelli L., and Dawson T.M. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med 36 (2004) 315-320
75. Pickart C.M. Polyubiquitin chains. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 19-63
76. Prasad K.N., Cole W.C., and Prasad K.C. Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Am Coll Nutr 21 (2002) 506-522
77. Pril R.d., Fischer D.F., Maat-Schieman M.L., Hobo B., Vos R.A.d., Brunt E.R., et al. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. Hum Mol Genet 13 (2004) 1803-1813
78. Qureshi N., Vogel S.N., Van Way III C., Papasian C.J., Qureshi A.A., and Morrison D.C. The proteasome: a central regulator of inflammation and macrophage function. Immunol Res 31 (2005) 243-260
79. Realini C., and Rechsteiner M. A proteasome activator subunit binds calcium. J Biol Chem 270 (1995) 29664-29667
80. Rechsteiner M. The 26S proteasome. In: Peters J.-M., Harris J.A., and Finley D. (Eds). Ubiquitin and the biology of the cell (1998), Plenum Press, New York, London 147-190
81. Rockwell P., Yuan H., Magnusson R., and Figueiredo-Pereira M.E. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys 374 (2000) 325-333
82. Schmidt M., Hanna J., Elsasser S., and Finley D. Proteasome-associated proteins: regulation of a proteolytic machine. Biol Chem 386 (2005) 725-737
83. Schmitt H.P. Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration: draft of a comprehensive theory for Alzheimer disease. Med Hypoth 65 (2005) 1106-1119
84. Schnell J.D., and Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem 278 (2003) 35857-35860
85. Schonlein C., Probst A., and Huber G. Characterization of proteases with the specificity to cleave at the secretase-site of β-APP. Neurosci Lett 161 (1993) 33-36
86. Selkoe D.J. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17 (1994) 489-517
87. Snider B.J., Tee L.Y., Canzoniero L.M., Babcock D.J., and Choi D.W. NMDA antagonists exacerbate neuronal death caused by proteasome inhibition in cultured cortical and striatal neurons. Eur J Neurosci 15 (2002) 419-428
88. Steiner H., Capell A., Pesold B., Citron M., Kloetzel P.M., Selkoe D.J., et al. Expression of Alzheimer's disease associated presenilin 1 is controlled by proteolytic degradation and complex formation. J Biol Chem 273 (1998) 32322-32331
89. Takashima A. Biochemistry of presenilin 1. Rinsho Shikeigaku 37 (1997) 1097-1098
90. Terriff D.L., Chik C.L., Price D.M., and Ho A.K. Proteasomal proteolysis in the adrenergic induction of arylalkylamine-N-acetyltransferase in rat pinealocytes. Endocrinology 146 (2005) 4795-4803
91. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30 (1991) 572-580
92. Upadhya S.C., and Hegde A.N. Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies. Curr Pharm Des 11 (2005) 3807-3828
93. Upadhya S.C., Smith T.K., and Hegde A.N. Ubiquitin-proteasome-mediated CREB repressor degradation during induction of long-term facilitation. J Neurochem 91 (2004) 210-219
94. Urbe S. Ubiquitin and endocytic protein sorting. Essays Biochem 41 (2005) 81-98
95. Valera A.G., Diaz-Hernandez M., Hernandez F., Ortega Z., and Lucas J.J. The Ubiquitin-proteasome system in Huntington's disease. Neuroscientist 11 (2005) 583-594
96. Wanamaker C.P., Christianson J.C., and Green W.N. Regulation of nicotinic acetylcholine receptor assembly. Ann NY Acad Sci 998 (2003) 66-80
97. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., et al. Soluble oligomers of β-amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924 (2002) 133-140
98. Wood M.A., Kaplan M.P., Brensinger C.M., Guo W., and Abel T. Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus 15 (2005) 610-621
99. Zatta P., Lucchini R., van Rensburg S.J., and Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 62 (2003) 15-28
100. Zhan S.S., Beyreuther K., and Schmitt H.P. Neuronal ubiquitin and neurofilament expression in different lysososmal storage disorders. Clin Neuropathol 11 (1992) 251-255